Xiao-lu Li
Soochow, 215003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The RNA polymerase II subunit B (RPB2) functions as a growth regulator in human glioblastoma.
Journal: Biochemical and biophysical research communications
Published: May 28, 2023
The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma.
Journal: Journal of immunology research
Published: July 27, 2022
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 01, 2022
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma.
Journal: Cell & bioscience
Published: December 14, 2021
SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7.
Journal: Cell death & disease
Published: October 27, 2021
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1.
Journal: Cancer cell international
Published: July 27, 2021
Analysis of the risk factor for the poor prognosis of localized neuroblastoma after the surgical.
Journal: Medicine
Published: October 07, 2018
Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.
Journal: Oncology reports
Published: September 01, 2016
Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells.
Journal: Cancer cell international
Published: July 29, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026